期刊文献+

纤维连接蛋白瓜氨酸化后对聚蛋白多糖酶-1活性的影响

Fibronectin decreases its inhibiting activity on disintegrin and metalloproteinase with thrombospondinmotifs-4 by citrullination
原文传递
导出
摘要 目的通过观察聚蛋白多糖酶-1(ADAMTS-4)与纤维连接蛋白(FN)以及瓜氨酸化的FN(cFN)的结合活性及结合后的酶解活性,探讨ADAMTS-4的活性调节机制。方法应用肽酰基精氨酸脱亚胺酶4(PADl4)对纤维连接蛋白(FN)进行瓜氨酸化并采用蛋白印迹法进行验证;应用酶联免疫吸附法测定FN和CFN与2种不同相对分子质量的ADAMTS-4的结合活性;使用聚蛋白多糖酶活性分析试剂盒测定2种ADAMTS-4的活性和其与FN、cFN结合后酶活性的变化。统计分析采用单因素方差分析,LSD-t检验或t检验。结果蛋白印迹法证实PADl4可以使FN瓜氨酸化为cFN;cFN与相对分子质量为93000的ADAMTS-4的结合活性明显低于FN(分别为0.624+0.033,2.1824-0.042;t:50.522,P〈0.01),而两者与缺失碳端的相对分子质量为53000的ADAMTS.4的结合活性差异无统计学意义(分别为0.934+0.012,0.971±0.024;t=2.388,P〉0.05)。相对分子质量为93000的ADAMTS.4能够酶解聚蛋白多糖产生大量酶解产物[ARGxx肽段浓度:(0.908±0.088)nmol/L],与FN结合后降解聚蛋白多糖的能力明显下降[ARGxx肽段浓度:(0.5734-0.000)nmol/L,P〈0.05],与cFN孵育后的ADAMTS-4降解聚蛋白多糖产生的ARGxx肽段浓度[(0.8304-0.020)nmol/L]明显高于与FN孵育后产生的ARGxx肽段浓度[(O.5734-0.000)nmol/L,P〈0.05]。相对分子质量为53000的ADAMTS-4的酶活性在与FN或eFN孵育前后酶活性无明显变化(P均〉0.05)。结论FN能结合ADAMTS-4并抑制它的活性,PADl4能将FN转化为cFN,cFN与ADAMTS-4的结合活性明显降低,从而对ADAMTS-4的活性抑制作用减弱。 Objective To observe the inhibiting activities of fibronectin (FN) and citrullinated fibre- nectin (cFN) on disintegrin and metalloproteinase with thrombospondin motifs-4 (ADAMTS-4), and to explore the extracellular regulative mechanisms of ADAMTS-4. Methods FN was incubated with peptidylarginine deaminase type 4 (PADI4). Western blotting analysis was used to verify the citrullination of FN. The binding activity of FN and cFN to ADAMTS-4 were investigated by enzyme-linked immunosorbent assay (ELISA). The pretealytic ability of ADAMTS-4 after binding to FN and :cFN were measured with the aggrecanase activity assay kit. One-way ANOVA, LSD-t test and t-test were used for statistical analysis. Results The immuno- signal of citrulline was detected in FN after incubated with PADI4, hut not in the absence of PADI4. A higher absorbance at 405 nm was detected when the full-length ADAMTS-4 protein was incubated with FN (2.182± 0.042) than cFN (0.624+0.033; t=50.522, P〈0.01). Additionally, the recombinant ADAMTS-4 protein with a truncation at the C-terminus displayed low absorbance at 405 nm when the enzyme was incubated with both FN(0.971±0.024) and cFN(0.934±0.012; t=2.388, P〉0.05). Large amounts of ARGxx peptide were detected with full-length ADAMTS-4 in aggrecanase activity assay [ (0.908±0.088) nmol/L], but significantly less whenin the presence of FN and ADAMTS-4 [ (0.573±0.000) nmol/L, P〈0.05 ]. The production of this peptide was more when full-length ADAMTS-4 was incubated with cFN [ (0.830+0.020) nmol/L, P〈0.05 ] than with FN. The reaction containing the truncated ADAMTS-4 without FN or cFN yielded the highest concentration of ARGxx peptide [(36.420±3.673) nmol/L], peptide production was not significantly altered when FN [(41.099±0.101) nmol/L] or cFN [(41.064±0.083) nmol/L] were added to the reaction. Conclusion FN could bind to ADAMTS-4 and inhibit its proteolytic activity. After citndlinated by PADI4, the binding activity of cFN is weakened and less inhibition to ADAMTS-4.
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2013年第4期259-263,I0002,共6页 Chinese Journal of Rheumatology
基金 山东省自然科学基金(Y2007C132)
关键词 连接蛋白类 瓜氨酸 聚蛋白多糖酶1 肽酰基精氨酸脱亚胺酶4 Connexins Citrulline A disintegrin and metalloproteinase with thrombospondin motifs-4 Peptidylarginine deaminase type 4
  • 相关文献

参考文献14

  • 1Nagase H, Kashiwagi M. Aggrecanases and cartilage matrix de- gradation. Arthritis Res Ther, 2003, 5: 94-103.
  • 2闫新峰,常晓天,张明,汤继文,吕厚山,赵燕.ADAMTS-4在多种软骨中的表达[J].中华外科杂志,2008,46(3):228-229. 被引量:4
  • 3Yamanishi Y, Boyle DL, Clark M, et al. Expression and regula- tion of aggrecanase in arthritis: the role of TGF-beta. J Immunol, 2002, 168: 1405-1412.
  • 4Chang X, Yamada R, Suzuki A, et al. Localization of peptidy- larginine deiminase 4 (PADI4) and citmllinated protein in syn- ovial tissue of rheumatoid arthritis. Rheumatology (Oxford), 2005, 44: 40-50.
  • 5Jones JE, Causey CP, Knuekley B, et al. Protein arginine deim- inase 4 (PADI44): current understanding and future therapeuticpotential. Curt Opin Drug Discov Devel, 2009, 12: 616-627.
  • 6Hashimoto G, Shimoda M, Okada Y. ADAMTS4 (aggrecanase- 1 ) interaction with the C-terminal domain of fibronectin inhibits proteolysis of aggrecan. J Biol Chem, 2004, 279: 32483-32491.
  • 7Tortorella MD, Pratta M, Liu RQ, et al. Sites of aggrecan eleav- age by reeombinant human aggrecanase-1 (ADAMTS-4). J Biol Chem, 2000, 275: 18566-18573.
  • 8Kriegsmann J, Bemdt A, Hansen T, et al. Expression of fi- brencctin splice variants and oncofetal glycosylated fibrenectin in the synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Rheumatol Int, 2004, 24: 25-33.
  • 9Homandberg GA, Wen C, Hui F. Cartilage damaging activities of fibrenectin fragments derived from cartilage and synovial fluid. Osteoarthritis Cartilage, 1998, 6: 231-244.
  • 10蒋真,潘文友.自身精氨酸肽的瓜氨酸化与类风湿关节炎[J].中华风湿病学杂志,2008,12(1):61-64. 被引量:3

二级参考文献38

  • 1栗占国.抗原模糊识别——类风湿关节炎发病机制的新认识[J].现代免疫学,2004,24(4):265-267. 被引量:8
  • 2Flannery CR, Lark MW, Sandy JD. Identification of a stromelysin cleavage site within the interglobular domain of human aggrecan. Evidence for proteolysis at the site in vivo in human articular cartilage. J Biol Chem, 1992, 267 : 1008-1014.
  • 3Sandy JD, Flannery CR, Neame PJ, et al. Tile structure of aggreean fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu373-Ala374 bond of the interglohular domain. J Clin Invest, 1992,89 : 1512-1516.
  • 4Abbaszade l, Liu RQ, Yang F, et al. Cloning and characlerization of ADAMTSI 1, an aggrecanase from the ADAMTS family. J Biol Chem, 1999, 274:23443-23450.
  • 5Stanton H, Fosang AJ. Matrix metalloproteinases are active following guanidine hydrochloride extraction of cartilage : generation of DIPEN neoepitope during dialysis. Matrix Biol, 2002, 21:425-428.
  • 6Glasson SS, Askew R, Sheppard B, et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature, 2005, 434:644-648.
  • 7Masson-Bessiere C, Sebbag M, Girbal-Neuhauser E, et al. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol, 2001, 166: 4177-4184.
  • 8Zhao Y, Tian X, Li Z. Prevalence and clinical significance of antibodies to citrullinated fibrinogen (ACF) in Chinese patients with rheumatoid arthritis. Clin Rheumatol, 2007, 26: 1505- 1512.
  • 9Natt NK, Kaur H, Raghava GP. Prediction of transmembrane regions of beta-barrel proteins using ANN- and SVM-based methods. Proteins, 2004, 56: 11-18.
  • 10Bhasin M, Raghava GP. SVM based method for predicting HLA- DRB1 * 0401 binding peptides in an antigen sequence. Bioinformatics, 2004, 20: 421-423.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部